Keyword: ImmunoMet

Cash injection sets up first trial of ImmunoMet's lead cancer drug

by Phil Taylor

Wednesday, March 8, 2017

Texas biotech ImmunoMet raises $5 million in a second-round fundraising that paves the way for a first clinical trial of its lead cancer drug.

Subscribe to FierceBiotech to get industry news and updates delivered to your inbox.